Clinical trial
Non Contrast Magnetic Resonance Imaging to Measure Renal Transplant Perfusion and Fibrosis - Association With Function and Prognosis
NCT03705091 is registered in ClinicalTrials.gov with NHS Greater Glasgow and Clyde as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non Contrast Magnetic Resonance Imaging to Measure Renal Transplant Perfusion and Fibrosis - Association With Function and Prognosis
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 11, 2017
- Completion date
- March 20, 2019
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney diseases, end stage renal disease, kidney transplant failure and rejection, renal transplant rejection